Cited by 11Alzheimer's disease research and treatmentsDementia and Cognitive Impairment ResearchNeuropeptides and Animal Physiology

The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.

Amyloid-β production in aged guinea pigs: atropine-induced enhancement is reversed by naloxone

Ionov, Ilya D., Pushinskaya, Irina I.·2010·Neuroscience Letters

Abstract

Advanced age, cholinergic deficit, and elevated brain levels of enkephalin are associated with sporadic Alzheimer's disease. The influence of these factors on production of amyloidogenic peptides (Abeta) is uncertain. In the present experiments, the levels of 40/42 amino acid-residue Abeta were measured in the brain cortex of guinea pigs aged 15-16 weeks (young) and 25-26 months (aged). As was found, injections of atropine (21 days, 5mg/kg/day) increase Abeta levels in aged but not young animals. This atropine-induced effect was antagonized by simultaneous injections of naloxone (3mg/kg/day) whereas naloxone alone failed to affect Abeta accumulation. These results are discussed in the light of a possible "acetylcholine - Abeta" feedback loop and an influence of enkephalin on the loop function.

Overview

Integrity signals

Registry

Crossref · 10.1016/j.neulet.2010.06.010

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Flagged first, then by citations

Show all 2 references

Research works printed but not linked: 39

  1. Alessio, 1988, Age-related changes of methionine-enkephalin and β-endorphin/β-lipotropin immunoreactivity in human CSF, Life Sci., 43, 1545, 10.1016/0024-3205(88)90403-1 · DOI
  2. Beach, 2000, Cholinergic deafferentation of the rabbit cortex: a new animal model of Aβ deposition, Neurosci. Lett., 283, 9, 10.1016/S0304-3940(00)00916-2 · DOI · Paper page
  3. Beach, 2001, Reduction of cortical amyloid β levels in guinea pig brain after systemic administration of physostigmine, Neurosci. Lett., 310, 21, 10.1016/S0304-3940(01)02076-6 · DOI
  4. Beck, 2003, Guinea pigs as a nontransgenic model for APP processing in vitro and in vivo, Neurochem. Res., 28, 637, 10.1023/A:1022850113083 · DOI
  5. Bhargava, 1978, Effects of methionine-enkephalin and morphine on spontaneous locomotor activity, antagonism by naloxone, Pharmacol. Biochem. Behav., 9, 167, 10.1016/0091-3057(78)90160-0 · DOI
  6. Bloom, 1976, Endorphins: profound behavioral effects in rats suggest new etiological factors in mental illness, Science, 194, 630, 10.1126/science.185694 · DOI
  7. Davis, 1982, Cerebrospinal fluid acetylcholine, choline, and senile dementia of the Alzheimer's type, Psychopharmacol. Bull., 18, 193
  8. Fishman, 1975, Comparative in vivo distribution of opiate agonists and antagonists by means of double isotope techniques, Life Sci., 17, 1119, 10.1016/0024-3205(75)90333-1 · DOI
  9. Forgon, 1998, β-Peptide and its fragments induce acetylcholine release in in vitro basal forebrain tissue slices of rat brain, but do not affect the choline uptake, Neurobiology (Bp), 6, 359
  10. Fratiglioni, 2000, Incidence of dementia and major subtypes in Europe: a collaborative study of population-based cohorts. Neurologic Diseases in the Elderly Research Group, Neurology, 54, S10
  11. Haddjeri, 2004, In-vivo modulation of central 5-hydroxytryptamine (5-HT1A) receptor-mediated responses by the cholinergic system, Int. J. Neuropsychopharmacol., 7, 391, 10.1017/S1461145704004377 · DOI
  12. Hellström-Lindahl, 2004, Reduced levels of Aβ40 and Aβ42 in brains of smoking controls and Alzheimer's patients, Neurobiol. Dis., 15, 351, 10.1016/j.nbd.2003.11.024 · DOI
  13. Hellström-Lindahl, 2009, Comparison of Aβ levels in the brain of familial and sporadic Alzheimer's disease, Neurochem. Int., 55, 243, 10.1016/j.neuint.2009.03.007 · DOI
  14. Hung, 1993, Activation of protein kinase C inhibits cellular production of the amyloid β-protein, J. Biol. Chem., 268, 22959, 10.1016/S0021-9258(19)49409-X · DOI
  15. Ionov, 2007, Specific mechanism for blood inflow stimulation in brain area prone to Alzheimer's disease lesions, Int. J. Neurosci., 117, 1425, 10.1080/00207450601125733 · DOI
  16. Jhamandas, 1977, Enkephalin effects on release of brain acetylcholine, Nature, 269, 433, 10.1038/269433a0 · DOI
  17. Jhamandas, 1980, Action of enkephalin analogues and morphine on brain acetylcholine release: differential reversal by naloxone and an opiate pentapeptide, Br. J. Pharmacol., 71, 201, 10.1111/j.1476-5381.1980.tb10927.x · DOI
  18. Jia, 2004, Differential acetylcholine and choline concentrations in the cerebrospinal fluid of patients with Alzheimer's disease and vascular dementia, Chin. Med. J. (Engl.), 117, 1161
  19. Jorm, 1998, The incidence of dementia: a meta-analysis, Neurology, 51, 728, 10.1212/WNL.51.3.728 · DOI · Paper page
  20. Kandasamy, 1983, Hyperthermic responses to central injections of some peptide and non-peptide opioids in the guinea-pig, Neuropharmacology, 22, 621, 10.1016/0028-3908(83)90154-5 · DOI
  21. Lord, 1977, Endogenous opioid peptides, multiple agonists and receptors, Nature, 267, 495, 10.1038/267495a0 · DOI · Paper page
  22. Meilandt, 2008, Enkephalin elevations contribute to neuronal and behavioral impairments in a transgenic mouse model of Alzheimer's disease, J. Neurosci., 28, 5007, 10.1523/JNEUROSCI.0590-08.2008 · DOI
  23. Mizuno, 1996, Medial septal injection of naloxone elevates acetylcholine release in the hippocampus and induces behavioral seizures in rats, Brain Res., 713, 1, 10.1016/0006-8993(95)01287-7 · DOI
  24. Ogomori, 1989, β-Protein amyloid is widely distributed in the central nervous system of patients with Alzheimer's disease, Am. J. Pathol., 134, 243
  25. Petanceska, 2000, Ovariectomy and 17β-estradiol modulate the levels of Alzheimer's amyloid β peptides in brain, Exp. Gerontol., 35, 1317, 10.1016/S0531-5565(00)00157-1 · DOI
  26. Risser, 1996, Endogenous opioids in frontal cortex of patients with Down syndrome, Neurosci. Lett., 203, 111, 10.1016/0304-3940(95)12275-3 · DOI
  27. Rocha-de-Melo, 2008, Chronic neonatal exposure of rats to the opioid antagonist naloxone impairs propagation of cortical spreading depression in adulthood, Neurosci. Lett., 441, 315, 10.1016/j.neulet.2008.06.057 · DOI
  28. Roher, 2000, Cortical cholinergic denervation elicits vascular Aβ deposition, Ann. N. Y. Acad. Sci., 903, 366, 10.1111/j.1749-6632.2000.tb06388.x · DOI · Paper page
  29. Ruzicka, 1988, Depression of potassium-evoked striatal acetylcholine release by δ-receptor activation: inhibition by cholinoactive agents, Can. J. Physiol. Pharmacol., 66, 1487, 10.1139/y88-243 · DOI
  30. Selkoe, 2001, Alzheimer's disease results from the cerebral accumulation and cytotoxicity of amyloid β-protein, J. Alzheimers Dis., 3, 75, 10.3233/JAD-2001-3111 · DOI · Paper page
  31. Steger, 1980, Reduced ability of naloxone to stimulate LH and testosterone release in aging male rats; possible relation to increase in hypothalamic met5-enkephalin, Life Sci., 27, 747, 10.1016/0024-3205(80)90328-8 · DOI
  32. Steinerman, 2008, Distinct pools of β-amyloid in Alzheimer disease-affected brain: a clinicopathologic study, Arch. Neurol., 65, 906, 10.1001/archneur.65.7.906 · DOI · Paper page
  33. Svedberg, 2009, [(11)C]PIB-amyloid binding and levels of Aβ40 and Aβ42 in postmortem brain tissue from Alzheimer patients, Neurochem. Int., 54, 347, 10.1016/j.neuint.2008.12.016 · DOI
  34. Teng, 2010, A GPCR/secretase complex regulates β- and γ-secretase specificity for Aβ production and contributes to AD pathogenesis, Cell Res., 20, 138, 10.1038/cr.2010.3 · DOI
  35. Tohgi, 1994, Remarkable reduction in acetylcholine concentration in the cerebrospinal fluid from patients with Alzheimer type dementia, Neurosci. Lett., 177, 139, 10.1016/0304-3940(94)90064-7 · DOI
  36. Tohgi, 1996, Cerebrospinal fluid acetylcholine and choline in vascular dementia of Binswanger and multiple small infarct types as compared with Alzheimer-type dementia, J. Neural. Transm., 103, 1211, 10.1007/BF01271206 · DOI
  37. Verdile, 2004, Protein markers for Alzheimer disease in the frontal cortex and cerebellum, Neurology, 63, 1385, 10.1212/01.WNL.0000141848.45315.A6 · DOI
  38. White, 1977, Neocortical cholinergic neurons in elderly people, Lancet, 1, 668, 10.1016/S0140-6736(77)92114-6 · DOI
  39. Zou, 2006, Inhibition of neprilysin by infusion of thiorphan into the hippocampus causes an accumulation of amyloid β and impairment of learning and memory, J. Pharmacol. Exp. Ther., 317, 334, 10.1124/jpet.105.095687 · DOI

Cited by

Sorted by citations

See all 11

Metadata

Authors
Ionov, I. D., & Pushinskaya, I. I.
Affiliations
Russian Academy of Sciences (RU)
Venue
Neuroscience Letters
Publisher
Elsevier BV
Published
2010-08
Volume
480
Issue
1
Pages
83-86
ISSN
0304-3940 (ISSN-L)
OpenAlex
W2064848141
Cited by
11
References
2
Citations by year
2026: 1 · 2024: 3 · 2022: 1 · 2020: 1 · 2018: 1 · 2015: 1 · 2013: 1 · 2012: 1
FWCI
0.33
Type
journal article
Language
en
Open access
closed
Locations
  • Neuroscience Letters (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
  • Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuropeptides and Animal Physiology
Keywords
amyloid-beta, Alzheimer's disease, aging, atropine, naloxone, cholinergic deficit, enkephalin, acetylcholine, cerebral cortex, guinea pig
MeSH terms
Aging, Animals, Atropine, Cerebral Cortex, Enkephalins, Guinea Pigs, Male, Naloxone, Narcotic Antagonists, Amyloid beta-Peptides, Muscarinic Antagonists

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review